Table 2.
Estimates of general population anti-HCV-Ab prevalence, and number of anti-HCV positive people in the general population, by country, Europe, 2000-2009
| Country* (Reference) | Period | Area | Region | Sampling | N | % | 95% CI** | Remarks | Population size [36] | Number of inhabitants who are anti-HCV-Ab positive |
|---|---|---|---|---|---|---|---|---|---|---|
| Belgium [91] |
2003 |
regional |
Flanders |
random |
1.834 |
0,1 |
(0.1-0.4) & |
Oral fluid |
10.754.528 |
64.527 |
| Belgium [111] |
1993-1994 |
regional |
Flanders |
random |
4.055 |
0,9 |
(0.5-1.1) & |
|
|
|
| Bulgaria [112] |
1999-2000 |
regional |
South-Central |
convenience |
2.211 |
1,3 |
(1.2-1.4) & |
Standardized |
7.606.551 |
98.885 |
| Czech Republic [92] |
2001 |
nationwide |
- |
random |
2.658 |
0,2 |
(0.1-0.4)$ |
|
10.467.542 |
20.935 |
| France [113] |
1997 |
regional |
South |
convenience |
11.804 |
1,3 |
(1.1-1.5) & |
|
64.351.000 |
836563 |
| Germany [95] |
1998 |
nationwide |
- |
random |
6.748 |
0,4 |
(0.2-0.5) & |
|
82.050.000 |
328200 |
| Greece [96] |
1997-1998 |
regional |
Peloponnesos |
random |
1.500 |
0,5 |
(0.2-1.1) & |
|
11.257.285 |
112.573 |
| Greece [114] |
1997 |
regional |
Zakinthos |
random |
718 |
1,3 |
(0.6-2.4) $ |
|
|
|
| Italy [74] |
2002 |
regional |
North |
convenience |
956 |
2,6 |
(1.7-3.8) $ |
|
|
|
| Italy [115] |
1994-1995 |
regional |
North |
convenience |
2.154 |
3,3 |
(2.6-4.1) & |
|
|
|
| Italy [116] |
Not reported |
regional |
North |
convenience |
4.820 |
2,4 |
(2.0-2.8) & |
|
|
|
| Italy [117] |
Not reported |
regional |
Central |
convenience |
300 |
16,3 |
(12.0-20.6) & |
|
|
|
| Italy [97] |
1997 |
regional |
Central |
random |
250 |
22,4 |
(20.8-24.1) & |
|
|
|
| Italy [98] |
Not reported |
regional |
South |
random |
488 |
16,2 |
(13.0-19.8) $ |
|
|
|
| Italy [118] |
2000-2002 |
regional |
South |
convenience |
2.753 |
7,9 |
(6.9-9.0) $ |
|
|
|
| Italy [99] |
2002-2003 |
regional |
South |
random |
1.645 |
6,5 |
(5.3-7.7) & |
|
|
|
| Italy [100] |
1994-1995 |
regional |
Sardinia |
convenience |
3.324 |
3,2 |
(2,6-3,8) $ |
|
|
|
| Italy [101] |
1999-2000 |
regional |
Sicily |
random |
721 |
10,4 |
(8,2-12,9) $ |
|
|
|
| Netherlands [41] |
2004 |
regional |
Amsterdam |
random |
1.364 |
0,6 |
(0.1-1.1) & |
Standardized |
16.486.587 |
65.946 |
| Netherlands [119] |
2006 |
regional |
East |
convenience |
2.200 |
0,2 |
(0.1-0.5) $ |
|
|
|
| Poland [120] |
1999 |
regional |
North |
convenience |
2.561 |
1,9 |
(1.4-2.5) $ |
|
38.135.876 |
724.582 |
| Romania [121] |
2006-2008 |
nationwide |
- |
random |
8.039 |
3,5 |
(3.1-3.9) & |
|
21.498.616 |
752.452 |
| Spain [122] |
1996 |
regional |
Catalonia |
random |
2.142 |
2,5 |
(1.8-3.2) & |
Standardized |
45.828.172 |
916.563 |
| Spain [123] |
1997-1998 |
regional |
North |
random |
1.170 |
1,6 |
(1.0-2.6) & |
|
|
|
| Sweden [104] |
1991-1994 |
regional |
Malmö |
random |
5.533 |
0,4 |
(0,3-0,6) $ |
|
9.256.347 |
37.025 |
| Turkey [105] |
2006-2007 |
regional |
South West |
random |
2.852 |
1,0 |
(0,7-1,4) $ |
|
71.517.100 |
1.072.757 |
| Turkey [106] |
2002-2004 |
regional |
Central |
convenience |
1.320 |
2,2 |
(1,5-3,1) $ |
|
|
|
| Turkey [108] |
Not reported |
regional |
Central |
random |
1.095 |
2,1 |
(1,3-3,1) $ |
|
|
|
| United Kingdom [124] | 1996 | regional | England&Wales | residual | 6.401 | 0,7 | (0,1-0,5) $ | 61634599 | 431442 |
* No estimate of anti-HCV general population prevalence was found for Austria, Croatia, Cyprus, Denmark, Estonia, Finland, Former Yugoslav Republic of Macedonia, Hungary, Iceland, Ireland, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Slovakia, Slovenia and Switzerland.
** CI Confidence interval.
& CI provided in the original paper.
$ CI estimated by the exact method.